Table 2: Visual and anatomic outcomes following bevacizumab injection. | ||||||||||||||||||||||||||||||||||||||||||||||||||||

| ||||||||||||||||||||||||||||||||||||||||||||||||||||

values were obtained by Student’s -test for continuous variables and chi-square test for dichotomous variables.^{†}Percentages were calculated by dividing the area of hemorrhage absorption or change in nonperfusion areas by the area of the circle with a radius of 3600 m.^{‡}Negative numbers indicate the decrease in the area of nonperfusion during the time period.Boldface indicates statistical significance (). |